RespireRx Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc. is a biopharmaceutical company developing innovative and revolutionary treatments to combat disorders caused by disruption of neuronal signaling.

In the News

RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties

August 4, 2026

RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties

November 20, 2025

RespireRx Pharmaceuticals Inc. Announces NIH/NINDS Grant Award and Amended and Restated Patent License Agreement

November 19, 2025

NEWS: RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders,
Strategic and Potential Strategic Partners and Other Interested Parties

NEWS: RespireRx Reports Preclinical Pain Relief for their Non-Opioid Lead GABAkine